A cancer vaccine that induces neutralizing antibodies to gastrin was shown to improve survival in a murine model of pancreatic cancer and reduce metastases by decreasing components of the metastases cascade and EMT, including protein expression of paxillin, β-catenin, and MMP-7 [48]. The gene discussed is GAST; the disease is pancreatic neoplasm.